Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 chaarted trial
- Christos E. Kyriakopoulos
- , Yu Hui Chen
- , Michael A. Carducci
- , Glenn Liu
- , David F. Jarrard
- , Noah M. Hahn
- , Daniel H. Shevrin
- , Robert Dreicer
- , Maha Hussain
- , Mario Eisenberger
- , Manish Kohli
- , Elizabeth R. Plimack
- , Nicholas J. Vogelzang
- , Joel Picus
- , Matthew M. Cooney
- , Jorge A. Garcia
- , Robert S. DiPaola
- , Christopher J. Sweeney
- University of Wisconsin-Madison
- Dana-Farber Cancer Institute
- American College of Radiology Imaging Network Cancer Research Group
- Johns Hopkins University
- NorthShore University HealthSystem
- University of Virginia
- Northwestern University
- Mayo Clinic
- Comprehensive Cancer Centers of Nevada
- Washington University St. Louis
- Case Western Reserve University
- Cleveland Clinic Foundation
- University of Kentucky
- Harvard University
Research output: Contribution to journal › Article › peer-review
1009
Scopus
citations